Form 4: Intuitive Surgical CMO Sells Shares, Vests Equity

Intuitive Surgical's EVP & Chief Medical Officer, Myriam Curet, reported sales of common stock and the vesting of Restricted and Performance Stock Units under a pre-arranged trading plan.

Summary

• Myriam Curet, EVP & Chief Medical Officer, reported transactions in Intuitive Surgical Inc. (ISRG) common stock.
• On February 27, 2026, 2,345 shares of common stock were sold at $499.71 per share under a Rule 10b5-1 trading plan.
• On February 28, 2026, 1,002 Restricted Stock Units (RSUs) converted into common stock at an exercise price of $0.0.
• On February 28, 2026, 8,378 Performance Stock Units (PSUs) converted into common stock at an exercise price of $0.0, following the achievement of performance metrics.
• A total of 497 shares and 4,155 shares were withheld on February 28, 2026, at a price of $503.51 per share, to cover statutory tax withholding requirements related to the RSU and PSU settlements, respectively.
• Following these transactions, Myriam Curet beneficially owns shares indirectly through a Trust, with specific amounts varying per transaction type.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing. The vesting of significant equity awards (RSUs and PSUs) is a positive for the executive, reflecting earned compensation and achieved performance metrics. The sale of shares, while a reduction in direct ownership, was pre-planned under a 10b5-1 plan, mitigating any negative sentiment typically associated with insider sales.

Positives

• Achievement of performance criteria for Performance Stock Units (PSUs) indicates successful operational performance by the company or the individual's contribution.
• Vesting of Restricted Stock Units (RSUs) and PSUs represents compensation earned by the executive.

Negatives

• Sale of 2,345 shares of common stock by a key executive, although under a 10b5-1 plan, reduces direct ownership.
• Significant number of shares (4,155 and 497) withheld for tax purposes, reducing the net shares received by the executive.

Industry Context

StockSavvy.ai notes that routine insider transactions, especially those executed under Rule 10b5-1 plans, are common for executives in the medical device and surgical robotics industry as part of their compensation and personal financial planning. These transactions typically do not reflect a change in the executive's outlook on the company's prospects.

Stakeholder Impact

• Shareholders: Routine insider transactions under a 10b5-1 plan generally have minimal direct impact on shareholders, as they are pre-scheduled and often for personal financial planning or tax purposes. The vesting of PSUs indicates performance criteria were met, which could be seen positively.
• Employees: The vesting of equity awards is a standard component of executive compensation, aligning executive interests with company performance.

Key Dates

Recommendation

The filing details routine insider transactions, including the vesting of equity awards and a pre-planned sale of shares by a key executive. These actions are typical for executive compensation and personal financial management and do not indicate a fundamental shift in the company's prospects or the executive's confidence. Therefore, a 'hold' recommendation is appropriate as this filing provides no new information to alter an existing investment thesis.

Keywords

Intuitive Surgical, ISRG, SEC Form 4, Insider Trading, Stock Sale, RSU Vesting, PSU Vesting, Executive Compensation, Myriam Curet, 10b5-1 Plan